Humana (HUM) Competitors

Humana (NYSE:HUM) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, community ranking, risk, valuation, analyst recommendations, dividends, earnings and profitability.

Which has higher valuation and earnings, HUM or ELV?

Elevance Health has higher revenue and earnings than Humana. Elevance Health is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humana	$117.76B	0.29	$1.21B	$9.95	28.64
Elevance Health	$176.81B	0.56	$5.98B	$25.61	17.14

Is HUM or ELV a better dividend stock?

Humana pays an annual dividend of $3.54 per share and has a dividend yield of 1.2%. Elevance Health pays an annual dividend of $6.84 per share and has a dividend yield of 1.6%. Humana pays out 35.6% of its earnings in the form of a dividend. Elevance Health pays out 26.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has increased its dividend for 14 consecutive years. Elevance Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Is HUM or ELV more profitable?

Elevance Health has a net margin of 3.38% compared to Humana's net margin of 1.02%. Elevance Health's return on equity of 18.28% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Humana	1.02%	11.70%	3.99%
Elevance Health	3.38%	18.28%	6.72%

Do insiders & institutionals believe in HUM or ELV?

92.4% of Humana shares are held by institutional investors. Comparatively, 89.2% of Elevance Health shares are held by institutional investors. 0.4% of Humana shares are held by insiders. Comparatively, 0.4% of Elevance Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Do analysts rate HUM or ELV?

Humana currently has a consensus price target of $284.90, suggesting a potential downside of 0.04%. Elevance Health has a consensus price target of $514.41, suggesting a potential upside of 17.17%. Given Elevance Health's stronger consensus rating and higher possible upside, analysts plainly believe Elevance Health is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Humana	0 Sell rating(s)	17 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.26
Elevance Health	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.89

Which has more risk and volatility, HUM or ELV?

Humana has a beta of 0.62, meaning that its share price is 38% less volatile than the S&P 500. Comparatively, Elevance Health has a beta of 0.77, meaning that its share price is 23% less volatile than the S&P 500.

Does the media refer more to HUM or ELV?

In the previous week, Humana had 3 more articles in the media than Elevance Health. MarketBeat recorded 53 mentions for Humana and 50 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.25 beat Humana's score of 1.01 indicating that Elevance Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Humana	28 Very Positive mention(s)	4 Positive mention(s)	15 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Elevance Health	35 Very Positive mention(s)	0 Positive mention(s)	11 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community favor HUM or ELV?

Humana received 22 more outperform votes than Elevance Health when rated by MarketBeat users. However, 67.23% of users gave Elevance Health an outperform vote while only 62.62% of users gave Humana an outperform vote.

Company	Underperform	Outperform
Humana	Outperform Votes 898 62.62%	Underperform Votes 536 37.38%
Elevance Health	Outperform Votes 876 67.23%	Underperform Votes 427 32.77%

Summary

Elevance Health beats Humana on 17 of the 22 factors compared between the two stocks.